The association of tidal EFL with exercise performance, exacerbations, and death in COPD

References

• LozanoRNaghaviMForemanKGlobal and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010Lancet201238098592095212823245604
   PubMed Web of Science ®Google Scholar
• From the Global Strategy for the Diagnosis, Management and Prevention of COPDGlobal Initiative for Chronic Obstructive Lung Disease (GOLD) 2017 Available from: http://goldcopd.org/gold-2017-global-strategy-diagnosis-management-prevention-copd/Accessed April 18, 2017
   Google Scholar
• SorianoJBAlfagemeIAlmagroPDistribution and prognostic validity of the new Global Initiative for Chronic Obstructive Lung Disease grading classificationChest2013143369470223187891
   PubMed Web of Science ®Google Scholar
• FranciosiLGPageCPCelliBRMarkers of disease severity in chronic obstructive pulmonary diseasePulm Pharmacol Ther200619318919916019244
   PubMed Web of Science ®Google Scholar
• GelbAFHoggJCMüllerNLContribution of emphysema and small airways in COPDChest199610923533598620705
   PubMed Web of Science ®Google Scholar
• Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 20112011 Available from: www.goldcopd.orgAccessed January 2, 2012
   Google Scholar
• HyattREThe interrelationships of pressure, flow, and volume during various respiratory maneuvers in normal and emphysematous subjectsAm Rev Respir Dis19618367668313717137
   PubMed Web of Science ®Google Scholar
• O’DonnellDEVentilatory limitations in chronic obstructive pulmonary diseaseMed Sci Sports Exerc2001337 SupplS647S65511462073
   PubMed Web of Science ®Google Scholar
• CalverleyPMKoulourisNGFlow limitation and dynamic hyperinflation: key concepts in modern respiratory physiologyEur Respir J200525118619915640341
   PubMed Web of Science ®Google Scholar
• DiazOVillafrancaCGhezzoHRole of inspiratory capacity on exercise tolerance in COPD patients with and without tidal expiratory flow limitation at restEur Respir J200016226927510968502
   PubMed Web of Science ®Google Scholar
• EltayaraLBecklakeMRVoltaCAMilic-EmiliJRelationship between chronic dyspnea and expiratory flow limitation in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med19961546 Pt 1172617348970362
   PubMed Web of Science ®Google Scholar
• O’DonnellDEWebbKAExertional breathlessness in patients with chronic airflow limitation. The role of lung hyperinflationAm Rev Respir Dis19931485135113578239175
   PubMed Web of Science ®Google Scholar
• AarliBBCalverleyPMJensenRLEaganTMBakkePSHardieJAVariability of within-breath reactance in COPD patients and its association with dyspnoeaEur Respir J201545362563425359342
   PubMed Web of Science ®Google Scholar
• DellacàRLDuffyNPompilioPPExpiratory flow limitation detected by forced oscillation and negative expiratory pressureEur Respir J200729236337417079262
   PubMed Web of Science ®Google Scholar
• DellacàRLSantusPAlivertiADetection of expiratory flow limitation in COPD using the forced oscillation techniqueEur Respir J200423223224014979497
   PubMed Web of Science ®Google Scholar
• O’DonnellDELavenezianaPDyspnea and activity limitation in COPD: mechanical factorsCOPD20074322523617729066
   PubMedGoogle Scholar
• JetmalaniKTimminsSBrownNJExpiratory flow limitation relates to symptoms during COPD exacerbations requiring hospital admissionInt J Chron Obstruct Pulmon Dis20151093994525999709
   PubMed Web of Science ®Google Scholar
• VestboJAndersonWCoxsonHOECLIPSE investigatorsEvaluation of COPD longitudinally to identify predictive surrogate end-points (ECLIPSE)Eur Respir J200831486987318216052
   PubMed Web of Science ®Google Scholar
• MahlerDAWellsCKEvaluation of clinical methods for rating dyspneaChest19889335805863342669
   PubMed Web of Science ®Google Scholar
• FerrisBGEpidemiology Standardization Project (American Thoracic Society)Am Rev Respir Dis19781186 Pt 21120
   PubMed Web of Science ®Google Scholar
• Standardization of spirometry, 1994 update. American Thoracic SocietyAm J Respir Crit Care Med19951523110711367663792
   PubMed Web of Science ®Google Scholar
• OostveenEMacLeodDLorinoHERS Task Force on Respiratory Impedance MeasurementsThe forced oscillation technique in clinical practice: methodology, recommendations and future developmentsEur Respir J20032261026104114680096
   PubMed Web of Science ®Google Scholar
• GulsvikATostesonTBakkePHumerfeltSWeissSTSpeizerFEExpiratory and inspiratory forced vital capacity and one-second forced volume in asymptomatic never-smokers in NorwayClin Physiol200121664866011722472
   PubMedGoogle Scholar
• ATS Committee on Proficiency Standards for Clinical Pulmonary Function LaboratoriesATS statement: guidelines for the six-minute walk testAm J Respir Crit Care Med2002166111111712091180
   PubMed Web of Science ®Google Scholar
• PedersenAGEllingsenCLData quality in the Causes of Death RegistryTidsskr Nor Laegeforen2015135876877025947599
   PubMedGoogle Scholar
• KeeneONCalverleyPMJonesPWVestboJAndersonJAStatistical analysis of exacerbation rates in COPD: TRISTAN and ISOLDE revisitedEur Respir J2008321172418591336
   PubMed Web of Science ®Google Scholar
• PolkeyMISpruitMAEdwardsLDSix-minute-walk test in chronic obstructive pulmonary disease: minimal clinically important difference for death or hospitalizationAm J Respir Crit Care Med2013187438238623262518
   PubMed Web of Science ®Google Scholar
• GuenetteJAWebbKAO’DonnellDEDoes dynamic hyperinflation contribute to dyspnoea during exercise in patients with COPD?Eur Respir J201240232232922183485
   PubMed Web of Science ®Google Scholar
• MarinJMCarrizoSJGasconMSanchezAGallegoBCelliBRInspiratory capacity, dynamic hyperinflation, breathlessness, and exercise performance during the 6-minute-walk test in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med200116361395139911371407
   PubMed Web of Science ®Google Scholar
• SpruitMAPolkeyMICelliBEvaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) study investigatorsPredicting outcomes from 6-minute walk distance in chronic obstructive pulmonary diseaseJ Am Med Dir Assoc201213329129721778120
   PubMed Web of Science ®Google Scholar
• SinghSJPuhanMAAndrianopoulosVAn official systematic review of the European Respiratory Society/American Thoracic Society: measurement properties of field walking tests in chronic respiratory diseaseEur Respir J20144461447147825359356
   PubMed Web of Science ®Google Scholar
• HurstJRVestboJAnzuetoAEvaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) InvestigatorsSusceptibility to exacerbation in chronic obstructive pulmonary diseaseN Engl J Med2010363121128113820843247
   PubMed Web of Science ®Google Scholar
• JenkinsCRJonesPWCalverleyPMEfficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH studyRespir Res2009105919566934
   PubMed Web of Science ®Google Scholar
• ManninoDMThornDSwensenAHolguinFPrevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPDEur Respir J200832496296918579551
   PubMed Web of Science ®Google Scholar
• de BisschopCMartyMLTessierJFBarberger-GateauPDartiguesJFGuénardHExpiratory flow limitation and obstruction in the elderlyEur Respir J200526459460116204588
   PubMed Web of Science ®Google Scholar
• KoulourisNGValtaPLavoieAA simple method to detect expiratory flow limitation during spontaneous breathingEur Respir J1995823063137758567
   PubMed Web of Science ®Google Scholar
• CrimCCelliBEdwardsLDECLIPSE investigatorsRespiratory system impedance with impulse oscillometry in healthy and COPD subjects: ECLIPSE baseline resultsRespir Med201110571069107821481577
   PubMed Web of Science ®Google Scholar
• O’DonnellDEBertleyJCChauLKWebbKAQualitative aspects of exertional breathlessness in chronic airflow limitation: pathophysiologic mechanismsAm J Respir Crit Care Med199715511091159001298
   PubMed Web of Science ®Google Scholar
• GlaxoSmithKlineEvaluation of COPD (Chronic Obstructive Pulmonary Disease) to Longitudinally Identify Predictive Surrogate Endpoints (ECLIPSE) Available from: https://clinicaltrials.gov/show/NCT0292552?. NLM identifier: NCT0292552Accessed April 4, 2017
   Google Scholar